Skip to content

Clinical trials

Completed Phase 3 Neurologic Manifestations trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurologic Manifestations Phase: Phase 3 Status: Completed Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20071
20081
20101
20142
20151
20161
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)9
National Institute of Neurological Disorders and Stroke (NINDS)4
Auspex Pharmaceuticals, Inc.2
Bayer1
Eli Lilly and Company1
Ethicon, Inc.1
Ipsen1
Medicure1
Mesoblast, Ltd.1
National Heart, Lung, and Blood Institute (NHLBI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurologic Manifestations26
Mental Disorders14
Rare Diseases13
Nervous System Diseases5
Central Nervous System Diseases4
Pain4
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating3
Seizures3
Dyskinesias2
Epilepsy2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.